About
Focus
Pipeline
Patients
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Focus
Pipeline
Patients
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
2018 American Society of Clinical Oncology (ASCO) Annual Meeting
2018 American Society of Clinical Oncology (ASCO) Annual Meeting
June 2018
A Phase 1/2 Study Evaluating the Efficacy and Safety of the Oral CXCR4 Inhibitor X4P-001 in Combination with Axitinib in Patients with Advanced Renal Cell Carcinoma
© 2023 X4 Pharmaceuticals, Inc. All rights reserved.
Terms of Use
|
Privacy Policy